Surface Plasmon Resonance (SPR) - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509245788

Publication Date:

September 16, 2024

Pages:

110

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Surface plasmon resonance (SPR) is the collective oscillation of conduction band electrons that are in resonance with the oscillating electric field of incident light, which will produce energetic plasmonic electrons through non-radiative excitation.
The global market for Surface Plasmon Resonance (SPR) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Surface Plasmon Resonance (SPR) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Surface Plasmon Resonance (SPR) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Surface Plasmon Resonance (SPR) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Surface Plasmon Resonance (SPR) include GE Healthcare, Bio-Rad Laboratories, Biosensing Instruments, Horiba, Reichert Technologies, AMETEK Inc, General Electric Co, Bruker and Nicoya Lifescience, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Surface Plasmon Resonance (SPR), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Surface Plasmon Resonance (SPR) by region & country, by Type, and by Application.
The Surface Plasmon Resonance (SPR) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Surface Plasmon Resonance (SPR).
麻豆原创 Segmentation
By Company
GE Healthcare
Bio-Rad Laboratories
Biosensing Instruments
Horiba
Reichert Technologies
AMETEK Inc
General Electric Co
Bruker
Nicoya Lifescience
Carterra Bristol Myers Squibb
Segment by Type:
Sensor System
Imaging System
Others
Segment by Application
Drug Discovery
Material Science
Biosensors
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Surface Plasmon Resonance (SPR) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Surface Plasmon Resonance (SPR) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Surface Plasmon Resonance (SPR) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Surface Plasmon Resonance (SPR) Product Introduction
1.2 Global Surface Plasmon Resonance (SPR) 麻豆原创 Size Forecast
1.3 Surface Plasmon Resonance (SPR) 麻豆原创 Trends & Drivers
1.3.1 Surface Plasmon Resonance (SPR) Industry Trends
1.3.2 Surface Plasmon Resonance (SPR) 麻豆原创 Drivers & Opportunity
1.3.3 Surface Plasmon Resonance (SPR) 麻豆原创 Challenges
1.3.4 Surface Plasmon Resonance (SPR) 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Surface Plasmon Resonance (SPR) Players Revenue Ranking (2023)
2.2 Global Surface Plasmon Resonance (SPR) Revenue by Company (2019-2024)
2.3 Key Companies Surface Plasmon Resonance (SPR) Manufacturing Base Distribution and Headquarters
2.4 Key Companies Surface Plasmon Resonance (SPR) Product Offered
2.5 Key Companies Time to Begin Mass Production of Surface Plasmon Resonance (SPR)
2.6 Surface Plasmon Resonance (SPR) 麻豆原创 Competitive Analysis
2.6.1 Surface Plasmon Resonance (SPR) 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Surface Plasmon Resonance (SPR) Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Surface Plasmon Resonance (SPR) as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Sensor System
3.1.2 Imaging System
3.1.3 Others
3.2 Global Surface Plasmon Resonance (SPR) Sales Value by Type
3.2.1 Global Surface Plasmon Resonance (SPR) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Surface Plasmon Resonance (SPR) Sales Value, by Type (2019-2030)
3.2.3 Global Surface Plasmon Resonance (SPR) Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Drug Discovery
4.1.2 Material Science
4.1.3 Biosensors
4.2 Global Surface Plasmon Resonance (SPR) Sales Value by Application
4.2.1 Global Surface Plasmon Resonance (SPR) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Surface Plasmon Resonance (SPR) Sales Value, by Application (2019-2030)
4.2.3 Global Surface Plasmon Resonance (SPR) Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Surface Plasmon Resonance (SPR) Sales Value by Region
5.1.1 Global Surface Plasmon Resonance (SPR) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Surface Plasmon Resonance (SPR) Sales Value by Region (2019-2024)
5.1.3 Global Surface Plasmon Resonance (SPR) Sales Value by Region (2025-2030)
5.1.4 Global Surface Plasmon Resonance (SPR) Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Surface Plasmon Resonance (SPR) Sales Value, 2019-2030
5.2.2 North America Surface Plasmon Resonance (SPR) Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Surface Plasmon Resonance (SPR) Sales Value, 2019-2030
5.3.2 Europe Surface Plasmon Resonance (SPR) Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Surface Plasmon Resonance (SPR) Sales Value, 2019-2030
5.4.2 Asia Pacific Surface Plasmon Resonance (SPR) Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Surface Plasmon Resonance (SPR) Sales Value, 2019-2030
5.5.2 South America Surface Plasmon Resonance (SPR) Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Surface Plasmon Resonance (SPR) Sales Value, 2019-2030
5.6.2 Middle East & Africa Surface Plasmon Resonance (SPR) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Surface Plasmon Resonance (SPR) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Surface Plasmon Resonance (SPR) Sales Value
6.3 United States
6.3.1 United States Surface Plasmon Resonance (SPR) Sales Value, 2019-2030
6.3.2 United States Surface Plasmon Resonance (SPR) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Surface Plasmon Resonance (SPR) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Surface Plasmon Resonance (SPR) Sales Value, 2019-2030
6.4.2 Europe Surface Plasmon Resonance (SPR) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Surface Plasmon Resonance (SPR) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Surface Plasmon Resonance (SPR) Sales Value, 2019-2030
6.5.2 China Surface Plasmon Resonance (SPR) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Surface Plasmon Resonance (SPR) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Surface Plasmon Resonance (SPR) Sales Value, 2019-2030
6.6.2 Japan Surface Plasmon Resonance (SPR) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Surface Plasmon Resonance (SPR) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Surface Plasmon Resonance (SPR) Sales Value, 2019-2030
6.7.2 South Korea Surface Plasmon Resonance (SPR) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Surface Plasmon Resonance (SPR) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Surface Plasmon Resonance (SPR) Sales Value, 2019-2030
6.8.2 Southeast Asia Surface Plasmon Resonance (SPR) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Surface Plasmon Resonance (SPR) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Surface Plasmon Resonance (SPR) Sales Value, 2019-2030
6.9.2 India Surface Plasmon Resonance (SPR) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Surface Plasmon Resonance (SPR) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GE Healthcare
7.1.1 GE Healthcare Profile
7.1.2 GE Healthcare Main Business
7.1.3 GE Healthcare Surface Plasmon Resonance (SPR) Products, Services and Solutions
7.1.4 GE Healthcare Surface Plasmon Resonance (SPR) Revenue (US$ Million) & (2019-2024)
7.1.5 GE Healthcare Recent Developments
7.2 Bio-Rad Laboratories
7.2.1 Bio-Rad Laboratories Profile
7.2.2 Bio-Rad Laboratories Main Business
7.2.3 Bio-Rad Laboratories Surface Plasmon Resonance (SPR) Products, Services and Solutions
7.2.4 Bio-Rad Laboratories Surface Plasmon Resonance (SPR) Revenue (US$ Million) & (2019-2024)
7.2.5 Bio-Rad Laboratories Recent Developments
7.3 Biosensing Instruments
7.3.1 Biosensing Instruments Profile
7.3.2 Biosensing Instruments Main Business
7.3.3 Biosensing Instruments Surface Plasmon Resonance (SPR) Products, Services and Solutions
7.3.4 Biosensing Instruments Surface Plasmon Resonance (SPR) Revenue (US$ Million) & (2019-2024)
7.3.5 Horiba Recent Developments
7.4 Horiba
7.4.1 Horiba Profile
7.4.2 Horiba Main Business
7.4.3 Horiba Surface Plasmon Resonance (SPR) Products, Services and Solutions
7.4.4 Horiba Surface Plasmon Resonance (SPR) Revenue (US$ Million) & (2019-2024)
7.4.5 Horiba Recent Developments
7.5 Reichert Technologies
7.5.1 Reichert Technologies Profile
7.5.2 Reichert Technologies Main Business
7.5.3 Reichert Technologies Surface Plasmon Resonance (SPR) Products, Services and Solutions
7.5.4 Reichert Technologies Surface Plasmon Resonance (SPR) Revenue (US$ Million) & (2019-2024)
7.5.5 Reichert Technologies Recent Developments
7.6 AMETEK Inc
7.6.1 AMETEK Inc Profile
7.6.2 AMETEK Inc Main Business
7.6.3 AMETEK Inc Surface Plasmon Resonance (SPR) Products, Services and Solutions
7.6.4 AMETEK Inc Surface Plasmon Resonance (SPR) Revenue (US$ Million) & (2019-2024)
7.6.5 AMETEK Inc Recent Developments
7.7 General Electric Co
7.7.1 General Electric Co Profile
7.7.2 General Electric Co Main Business
7.7.3 General Electric Co Surface Plasmon Resonance (SPR) Products, Services and Solutions
7.7.4 General Electric Co Surface Plasmon Resonance (SPR) Revenue (US$ Million) & (2019-2024)
7.7.5 General Electric Co Recent Developments
7.8 Bruker
7.8.1 Bruker Profile
7.8.2 Bruker Main Business
7.8.3 Bruker Surface Plasmon Resonance (SPR) Products, Services and Solutions
7.8.4 Bruker Surface Plasmon Resonance (SPR) Revenue (US$ Million) & (2019-2024)
7.8.5 Bruker Recent Developments
7.9 Nicoya Lifescience
7.9.1 Nicoya Lifescience Profile
7.9.2 Nicoya Lifescience Main Business
7.9.3 Nicoya Lifescience Surface Plasmon Resonance (SPR) Products, Services and Solutions
7.9.4 Nicoya Lifescience Surface Plasmon Resonance (SPR) Revenue (US$ Million) & (2019-2024)
7.9.5 Nicoya Lifescience Recent Developments
7.10 Carterra Bristol Myers Squibb
7.10.1 Carterra Bristol Myers Squibb Profile
7.10.2 Carterra Bristol Myers Squibb Main Business
7.10.3 Carterra Bristol Myers Squibb Surface Plasmon Resonance (SPR) Products, Services and Solutions
7.10.4 Carterra Bristol Myers Squibb Surface Plasmon Resonance (SPR) Revenue (US$ Million) & (2019-2024)
7.10.5 Carterra Bristol Myers Squibb Recent Developments
8 Industry Chain Analysis
8.1 Surface Plasmon Resonance (SPR) Industrial Chain
8.2 Surface Plasmon Resonance (SPR) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Surface Plasmon Resonance (SPR) Sales Model
8.5.2 Sales Channel
8.5.3 Surface Plasmon Resonance (SPR) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

GE Healthcare
Bio-Rad Laboratories
Biosensing Instruments
Horiba
Reichert Technologies
AMETEK Inc
General Electric Co
Bruker
Nicoya Lifescience
Carterra Bristol Myers Squibb

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.